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Abstract
The diagnosis of inflammatory bowel disease (IBD) and the differentiation between 
Crohn’s disease and ulcerative colitis can be challenging. Colonoscopy with ileoscopy 
is the useful diagnostic test for patients with suspected inflammatory bowel disease. 
Esophagogastroduodenoscopy, enteroscopy, and capsule endoscopy all have comple-
mentary roles to ileocolonoscopy. Endoscopy not only allows for the visualization of 
inflammation due to IBD but also for histological analysis, both of which can aid the in 
proper diagnosis and to exclude other causes of enteritis and colitis. This chapter will 
describe the use of endoscopy for the diagnosis of IBD.
Keywords: inflammatory bowel disease, Crohn’s disease, ulcerative colitis, 
colonoscopy, diagnosis
1. Introduction
Colonoscopy is the most essential diagnostic tool for patients with suspected inflammatory 
bowel disease (IBD). Ileoscopy at the time of colonoscopy is critical to both diagnose IBD, 
differentiate between ulcerative colitis (UC) and Crohn’s disease (CD), and to determine the 
extent and distribution of inflammation as this will affect prognosis and treatment. Other 
endoscopic modalities including esophagogastroduodenoscopy (EGD), capsule endoscopy, 
and enteroscopy all have a role in the diagnosis of IBD in select situations. It is critical to 
understand the endoscopic features and perform the endoscopy appropriately to improve the 
diagnostic yield and differentiate between IBD and other causes that might mimic IBD as well 
as differentiating CD and UC as the medical and surgical treatments can be different. This 
chapter will focus on the practical approach of using endoscopy to diagnose IBD.
© 2018 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly cited.
2. Ileocolonoscopy
Colonoscopy with ileoscopy is the gold standard for the diagnosis of IBD. It allows for both 
direct visualization of the most commonly affected areas of bowel in patients with IBD and 
tissue sampling for histologic analysis. While the inflammation seen in UC is mainly lim-
ited to the colon, CD may present with inflammation anywhere from the mouth to anus. 
Therefore, any colonoscopy done to evaluate symptoms concerning for IBD, or less commonly 
if a patient is incidentally found to have colonic inflammation during colonoscopy, intubation 
of the terminal ileum should be attempted. If ileoscopy is successful, taking biopsies of the 
ileum and colon are also critical aspects of the diagnostic evaluation as this is more sensitive 
than visual evaluation of the mucosa to find evidence of inflammation.
2.1. Crohn’s disease
Crohn’s disease was initially described as regional ileitis in 1932 in which a new entity was 
described as being similar to UC but affecting the small intestine and leading to luminal ste-
nosis [1]. Since then, the endoscopic features and distribution of CD has been extensively 
elucidated. CD can affect any part of the alimentary tract from the mouth to the anus, but 
the terminal ileum and colon are most commonly affected. About 29% of patients with CD 
have involvement of both the ileum and colon, 35% have isolated ileitis, 36% of patients have 
colitis, and 4% have upper gastrointestinal tract involvement at the time of diagnosis. This 
distribution can evolve over time during a patient’s disease course and so these proportions 
may not stay static in a population with CD over time [2].
Findings on index ileocolonoscopy at the time of CD diagnosis vary depending on the sever-
ity of inflammation, but the distribution and pattern can be helpful in diagnosing CD. Skip 
lesions, areas of inflamed mucosa separated by normal appearing mucosa, is characteristic of 
CD [3, 4]. Rectal sparing occurs in at least 50% of patients. The inflammation is patchy and 
circumferential inflammation is uncommon [5, 6].
Mild inflammation presents endoscopically with erythema, granularity, altered vascular 
pattern, friability, and small discrete superficial and aphthous ulcers. As the inflammation 
progresses, deep, serpiginous, and linear ulcerations and cobblestoning develop (Figure 1). 
About one-third of patients with CD will develop a fistula over their lifetime. In perianal 
disease fistulas may be apparent on physical exam, and perianal fistulas are more commonly 
seen in patients with rectal inflammation. Endoscopically, fistula openings may be visible as 
small openings in the colon or ileal mucosa [7]. Strictures, perianal disease, and isolated ileitis 
are also indicative of but not 100% specific for CD [6, 8]. Because of the discontinuous inflam-
mation in CD, the area immediately surrounding inflammatory patches or ulcers are more 
likely to have an intact vascular pattern and absent or minimal inflammation on biopsy [9].
2.2. Ulcerative colitis
The inflammation seen in ulcerative colitis begins at the anal verge and extends proximally. 
Ulcerative colitis always involves the rectum, but if treatment has been started prior to 
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colonoscopy the rectum may be spared or there may be patchy rectal inflammation [10]. The 
proximal extent of inflammation varies—about 46% of patients with UC have proctosigmoid-
itis, 37% have left sided colitis, and 17% have pancolitis [11].
On colonoscopy the inflammation in UC is circumferential and continuous. The features 
vary depending on severity. Early and mild inflammation appears as erythema, edema, and 
abnormal vascularity. Moderate UC has a “wet sand-paper” appearance due to changes in 
light reflection, erosions, superficial ulcers, and friability. As the severity of inflammation 
progresses the ulcerations become confluent, friability worsens, and spontaneous bleeding 
may develop [12–14] (Figure 2a and 2b). Because the inflammation is continuous, the mucosa 
surrounding ulcerations will usually at a minimum have a diminished vascular pattern but 
more commonly will show more obvious signs of inflammation [9].
Pseudopolyps are also often seen in UC and develop as a result of regenerating epithelium 
but can be seen in CD as well [15]. They develop in patients with more severe and exten-
sive periods of inflammation. While pseudopolyps themselves are not at risk of malignant 
transformation, UC patients with pseudopolyps may have a higher incidence of colorectal 
cancer as a result of more severe inflammation that predisposes to pseudopolyp formation 
[15, 16]. Pseudopolyps do not need to be resected, but there can be difficulty in distinguishing 
between pseudopolyps and adenomatous tissue, in which case biopsies or resection should 
be performed [12].
Patients with UC may have two unique areas of inflammation that may that may be confused 
as representing CD. In patients without inflammation in the right colon, there may be a “cecal 
patch”, or localized inflammation around the appendiceal orifice (Figure 3). The prevalence 
of peri-appendiceal inflammation in UC is 5%. The significance of the cecal patch is uncertain, 
but its presence does not signify a more aggressive disease phenotype or higher colectomy 
rates [17]. Additionally, 10–25% of patients with pan-colonic UC have “backwash ileitis” 
which can be confused as representing CD. Backwash ileitis usually presents as localized, 
continuous, and short segment erythema in the terminal ileum without discrete ulcerations 
Figure 1. Terminal ileitis due to Crohn’s disease.
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or strictures and always occurs in the setting of pancolitis [18–20]. In contrast to peri-appen-
diceal inflammation, backwash ileitis represents a more severe disease course and increased 
risk for colectomy [21]. It should be noted that these observations are based on observational 
findings and one should not use these findings as definitive findings for distinguishing CD 
from UC. These findings further do not necessarily alter the medical management of IBD.
2.3. Biopsy collection
Biopsies should be obtained from both normal and abnormal appearing mucosa. A minimum 
of two biopsies should be taken from at least five sites throughout the colon including the 
rectum and terminal ileum. The biopsies should be labeled appropriately and separated so 
that the site of biopsy can be correlated with histology [13, 22, 23]. A full set of colonoscopic 
biopsies improves the diagnostic yield by histology for both CD and UC. Full biopsies may 
also reveal inflammation not seen well endoscopically that can affect prognosis and need for 
dysplasia surveillance [22]. Granulomas are present in patients with CD in at most 25% of 
patients at initial presentation and therefore cannot be used to differentiate between CD and 
UC when absent [24]. However, biopsies taken from micro-ulcers <5 mm in size and ulcer 
edges are more likely to demonstrate granulomas [25]. Terminal ileal biopsies are also vital in 
distinguishing UC from CD and for ruling out IBD mimickers.
2.4. Complications and contraindications
The complications seen in patients undergoing diagnostic ileocolonoscopy are similar to the 
general population. Complications include bleeding, perforation, and respiratory failure due 
to over sedation. It is not clear if IBD patients have an increased risk of perforation, with some 
studies finding no increased risk and others showing a higher rate of perforation, particularly in 
hospitalized IBD patients undergoing colonoscopy [26–29]. Full colonoscopy should be under-
taken with caution in patients with severe inflammation, in those unable to undergo full bowel 
Figure 2. Severe ulcerative colitis.
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prep because of severe symptoms, and definitely avoided in patients with toxic megacolon. In 
patients with severe disease and inflammation flexible sigmoidoscopy can be used for diagnosis 
and ruling out some infections, but sigmoidoscopy may not allow for differentiation between 
UC and CD. Despite these concerns, the overall rate of perforation is still very low. However, if 
perforation does occur it can require surgery and cause significant morbidity and even mortal-
ity and therefore caution should be taken in the presence of considerable inflammation.
3. Esophagogastroduodenoscopy
Although CD can involve any area from the mouth the anus, upper gastrointestinal (GI) tract 
involvement is less common than ileal or colonic inflammation. Because upper GI inflamma-
tion is often seen in patients without IBD, the prevalence is difficult to accurately determine 
but has been described in 13–55% of patients with IBD [30]. In terms of the distribution of 
upper GI tract involvement, one study found upper GI inflammation attributable to CD in 
the esophagus in 6.5%, upper-middle stomach in 47.8%, lower stomach in 24.6%, duodenal 
bulb in 31.9%, and second portion of the duodenum in 18.1% [31]. EGD is not necessary for 
all adult patients with suspected IBD but should be done for those with upper GI symptoms 
such nausea, vomiting, and early satiety. Endoscopic evaluation of the upper GI tract can also 
be useful when the diagnosis is uncertain.
EGD is recommended for pediatric patients with suspected IBD at the time of initial colo-
noscopy. There is a significantly higher proportion of pediatric patients with indeterminate 
colitis compared to adults, and EGD can help distinguish between CD and UC. There can 
also be inflammation with granulomas on biopsy even without colonic or ileal inflammation. 
Additionally, children can frequently present with non-specific symptoms such as weight loss 
or anemia for which an EGD is warranted to evaluate for IBD as well as other causes such as 
celiac disease [13, 32, 33].
Figure 3. Peri-appendiceal inflammation.
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3.1. Mucosal appearance and distribution
Esophageal Crohn’s disease can appear as scattered erosions and aphthous ulcers with mild-
moderate disease. More severe esophageal inflammation due to CD appears as longitudi-
nal ulcers and can even have a cobblestone appearance. Stricturing and fistulization of the 
esophagus is rare but does occur in 20 and 5%, respectively, of patients with esophageal CD 
[34]. Importantly, esophageal CD must be differentiated from other causes of esophageal 
inflammation including reflux disease, eosinophilic esophagitis, and infectious esophagitis as 
the medical and surgical treatment for each condition varies. Granulomas are detected in less 
than 25% of cases of esophageal CD and therefore the absence of granulomas cannot be used 
to exclude esophageal CD [31].
Gastric CD is the most commonly observed site of involvement in the upper GI tract. The 
endoscopic findings are relatively non-specific for CD and include erythema, aphthous or 
linear ulcers, and granularity most commonly in the antrum. Bamboo-joint-like appearance in 
the stomach, typically in the cardia and upper body, is more specific finding for CD. The bam-
boo-joint-like finding appears as edematous folds with fissures or linear furrows arranged 
transversely [35]. Notably, gastritis without ulceration is often seen in patients with UC and 
cannot be used to differentiate CD from UC [19].
Mucosal features of duodenal CD can also be frustratingly non-specific. Findings include 
erythema, edema, aphthous and longitudinal erosions and ulcerations. Duodenal CD may 
have protruding lesions in the second portion of the duodenum that arrange longitudinally 
or a notch-like appearance in the second portion of the duodenum that may a more reliable 
marker of inflammation due to CD [31, 35].
3.2. Biopsy collection
A minimum of two biopsies should be taken from the esophagus, stomach, and duodenum 
for patients undergoing EGD for suspected IBD. Biopsies should also be taken from the 
stomach to rule out Helicobacter pylori infection depending on the patient’s symptoms and 
endoscopic findings. More than two biopsies should be obtained from the esophagus and 
duodenum if there is concern for other diseases such as celiac disease or eosinophilic esopha-
gitis to improve the diagnostic yield of the procedure and directed biopsies should be taken 
of any visible lesions.
4. Endoscopic evaluation of the small intestine
Evaluation of the small bowel in patients with suspected CD can be useful when the diag-
nosis is uncertain after ileocolonoscopy or upper endoscopy. Enteroscopy is also valuable 
for therapeutic benefit in the setting of small bowel strictures at the time of diagnosis and is 
typically guided by radiographic imaging findings. There are multiple modalities for small 
bowel evaluation—capsule endoscopy (CE), push enteroscopy, and antegrade (via mouth) 
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or retrograde (via anus) device assisted enteroscopy. The benefit of push or device assisted 
enteroscopy is the ability to sample tissue for histology and for therapy in the case of strictur-
ing CD. For all afore mentioned modalities, they should be undertaken if the findings would 
change medical or surgical management of the patient and are not required prior to starting 
medical therapy.
4.1. Capsule endoscopy
Capsule endoscopy is important when the diagnosis of IBD is uncertain after EGD and colo-
noscopy with ileoscopy or in cases of indeterminate colitis. Capsule endoscopy is less invasive 
compared to standard endoscopy and allows for imaging of the entire small bowel that may 
not be easily reached even by device assisted enteroscopy. Additionally, CE has a similar or 
higher sensitivity compared to other small bowel imaging modalities such as small bowel fol-
low through, magnetic resonance enterography (MRE), or computed tomography enterogra-
phy (CTE). The main limitation of CE is the inability to obtain biopsies for histologic analysis, 
which can lead to diagnostic challenges as small bowel findings on CE may not be specific to 
IBD. An advantage of CE over small bowel imaging modalities is the ability to detect subtle 
inflammation that may not be seen on CTE or MRE [13, 36]. Another disadvantage of CE 
is that it can become retained in up to 5% of CD patients and may require enteroscopy or 
surgery for retrieval.
Small bowel inflammation due to IBD has a similar appearance to IBD elsewhere in the GI 
tract. This includes more subtle features such as erythema, granularity, loss of villi, and 
edema, to more prominent findings such as ulceration of varying sizes, strictures, and fistula 
openings [37, 38].
The main complication of capsule endoscopy is capsule retention. Because of the stricturing 
nature of CD, there is estimated to be a slightly higher risk of capsule retention compared 
to patients without CD. In patients with known or suspected strictures or with obstructive 
symptoms, assessment with patency capsule or alternative small bowel imaging modality 
(CTE or MRE) beforehand is imperative [39]. The risk of capsule retention in patients under-
going evaluation for suspected CD is lower than in patients with established CD but still 
occurs in about 1–2% of patients [40]. In cases of retention for longer than 2 weeks, the capsule 
should be retrieved. Occasionally, if a capsule is retained due to a small bowel stricture that 
is due at least in part to active inflammation, the capsule will eventually traverse a stricture 
if effective medical therapy is initiated. If unsuccessful, retrieval can be accomplished by bal-
loon or push enteroscopy, but in some cases surgical intervention is required.
4.2. Enteroscopy
The advantage of enteroscopy over CE is the ability to obtain tissue when the etiology of 
small bowel inflammation is uncertain. Additionally, enteroscopy can allow for dilation of 
small bowel strictures that may not be reached by standard colonoscopy with ileoscopy or 
EGD. Push enteroscopy is a technique in which a colonoscope, typically pediatric, is advanced 
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to the proximal jejunum. Double and single balloon enteroscopy is more technically challeng-
ing than push enteroscopy but can be advanced past the reach of push enteroscopy. Single 
or double balloon enteroscopy can be done antegrade (via the mouth) or retrograde (via the 
anus) depending on the site of suspected disease. Double balloon enteroscopy can be effective 
for the diagnosis and staging of suspected small bowel CD in 30–48% of cases but is not the 
preferred initial test [41, 42]. Findings on enteroscopy are the same as CE, namely erythema, 
edema, loss of villi, ulcerations, and possibly strictures and fistula openings. The major 
complication rate of balloon enteroscopy is 0.72% and includes perforation, pancreatitis, 
aspiration, and bleeding [43]. Complication rates of push enteroscopy are similar to balloon 
enteroscopy [44]. It should also be noted that enteroscopy whether antegrade or retrograde 
may not visualize the entirety of the small intestine and typically requires general anesthesia 
to complete.
5. Indeterminate colitis and differentiating UC and CD
The most important aspect of ileocolonoscopy for suspected IBD is making the correct diag-
nosis and staging the disease as this will affect prognosis and treatment. Ileocolonoscopy can 
differentiate UC from CD nearly 90% of the time. Indeterminate colitis is used for a small 
subset of patients with colitis cannot be easily classified into UC or CD by endoscopic findings 
or histology [45].
The pattern and distribution of inflammation is critical for distinguishing CD and UC. UC 
presents with continuous inflammation and in untreated UC always involves the rectum. In 
CD, rectal sparing is often present and the inflammation is patchy with intervening areas 
of normal mucosa. However, the presence of rectal inflammation can be seen in up to 50% 
of patients with CD is therefore not diagnostic of UC [8]. Additionally, because of the con-
tinuous nature of the inflammation in UC, the mucosa immediately surrounding ulceration 
will be abnormal. This is apparent as erythema or decreased vascular pattern around ulcers 
in UC. In CD, the mucosa around ulcers shows a normal vascular pattern and absence of 
inflammation [3, 4, 19]. Central to discriminating CD from UC is ileoscopy. While back-
wash ileitis can be present in up to 25% of UC patients with pancolitis, the inflammation in 
this setting is usually mild, continuous, and shorter. It should be noted that the definition 
of backwash ileitis is controversial and the term was initially created prior to the era of 
ileo-colonoscopy and was used to describe a finding on barium enema. The presence of 
ulcers in the terminal ileum in a patient without right colon inflammation is specific for 
CD compared to UC. However, it is important to remember that there are other causes of 
terminal ileitis, including infection, vasculitis, malignancy, or NSAID induced inflammation 
[46]. Inflammation, particularly ulceration, stricturing, or fistulization of the upper GI tract 
or small bowel, is virtually diagnostic of CD over UC, although mild gastritis or duodenitis 
without ulceration can be present in patients with UC. Granulomas, if present, are also con-
sistent with Crohn’s disease, and biopsies of the ulcer edge increase the chance of finding a 
granuloma [25].
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When a diagnosis of CD or UC cannot be made based on endoscopy, histology, and radi-
ography, the term indeterminate colitis or IBD-unclassified is used. About 7–10% of adult 
patients with IBD will have indeterminate colitis. An even higher proportion of children, 
nearly 30%, have indeterminate colitis [32, 45]. Some of these patients will be reclassified 
as CD or UC as the disease evolves and defining characteristics of UC or CD develop. 
EGD and CE may be helpful in establishing the correct diagnosis by revealing small bowel 
inflammation consistent with CD in about 15% of patients with indeterminate colitis. 
However, a normal EGD or CE study does not rule out CD [47]. If a patient is classified as 
indeterminate colitis, this should not affect therapy choices or present or future endoscopic 
evaluation.
6. Differentiating IBD from IBD mimickers based on endoscopy
The diagnosis of IBD relies on a combination of symptoms, laboratory analysis, imaging, 
endoscopy, and histology. However, the endoscopic inflammation in IBD can be non-specific 
and due to causes other than IBD. In addition to differentiating between CD and UC and 
staging the extent of disease, other causes of bowel inflammation should be ruled out. This 
is particularly important as the treatment for IBD may lead to worsening of other conditions, 
particularly infection.
6.1. Infection
Infection is an important mimicker of IBD on endoscopy. Common infections such as 
Clostridium difficile and Escherichia coli should be ruled out with stool testing prior to colo-
noscopy. Yersinia spp. can often lead to right lower quadrant abdominal pain and fever with 
imaging showing ileitis and an appearance suggestive of acute appendicitis. Salmonella, 
Actinomyces, and E. coli infections can also lead to enteritis and particularly ileitis that may 
look like IBD [48]. Intestinal tuberculosis can lead to ulceration, nodularity, and stricturing of 
the terminal ileum and ileocecal valve [49].
Cytomegalovirus (CMV) infection can lead to inflammation and ulceration in any part of the 
gastrointestinal tract. The ulcers in CMV enteritis or colitis have been described has having a 
“punched-out” appearance. Biopsies can help differentiate CMV from IBD. However, many 
patients with IBD will have coexisting CMV and endoscopy is important to rule out concomi-
tant CMV infection that is contributing to bowel inflammation. However, it can be sometimes 
challenging to determine whether CMV is an innocent bystander or an active participant in 
inflammation in IBD patients [50].
6.2. Vasculitis
Rarely, vasculitis can affect the bowel, typically the small intestine. Systemic lupus erythema-
tosis, polyarteritis nodosa, Henoch-Schönlein purpura, and Behçet’s disease may all be con-
fused with IBD. Polyarteritis nodosa frequently affects the gastrointestinal tract in up to 65% 
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of patients and may lead to symptoms of bowel ischemia [51]. Behçet’s disease in particular 
can lead to discrete ulcers in the small and large bowel with normal intervening mucosa that 
can be confused for CD. However, the ulcers in Behçet’s disease are usually fewer in number, 
larger, deeper, and rounder than seen in IBD [52].
6.3. Ischemia
Ischemia can lead to edema, erythema, erosions and ulcerations that can look similar to 
IBD. Severe ischemic colitis can lead to a dusky and even black appearance with necrosis. 
The inflammation is usually segmental with a sharp demarcation affected and unaffected 
mucosa depending on the vascular supply. The left colon is most commonly affected. An 
accurate history and acuity of symptoms can also help distinguish IBD from ischemic colitis 
[53, 54].
6.4. Segmental colitis associated diverticulosis syndrome
Segmental colitis associated diverticulosis (SCAD) can be especially difficult to distinguish 
from IBD. SCAD is associated with diverticulosis and most commonly affects the sigmoid 
colon. The rectum and right colon are typically spared. The endoscopic features of SCAD 
include edema, erythema, erosions, and ulcers, often with sparing of the diverticular ori-
fices [55]. Because endoscopic and histologic features overlap with IBD, the diagnosis can 
be challenging but SCAD is more often found in older patients and often responds to mesa-
lamine [56].
6.5. NSAID enteropathy
NSAIDs are the most common medication that can lead to bowel inflammation. NSAIDs can 
lead to “diaphragm disease” or pinhole openings due to 2–3 mm thin walled septae with 
normal mucosa between diaphragms. NSAIDs can also lead to erosions and ulcers not just in 
the stomach and duodenum but small bowel as well [48].
7. Novel techniques and future directions
This section will discuss techniques that are available or being developed but not widely 
utilized or have not been evaluated sufficiently to recommend that these techniques be used 
as standard of care.
7.1. Endoscopic ultrasound
Although still being studied, endoscopic ultrasound (EUS) is emerging as technique that can 
be valuable for the diagnosis of IBD and differentiation between CD and UC. In one study 
comparing EUS in IBD patients to healthy controls, patients with active IBD undergoing 
EUS had increased total wall thickness of the sigmoid colon compared to healthy controls. 
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Furthermore, patients with UC had increased wall thickness of the mucosa with normal sub-
mucosa and muscularis propria, whereas CD patients had increased submucosa thickness 
with normal mucosa thickness [57]. In addition to being used to assess bowel inflammation, 
EUS has a recognized role in the diagnosis and evaluation of CD related perianal disease. EUS 
can determine fistula anatomy with accuracy that is slightly higher than MRI (91% vs. 87%). 
EUS can also assess for adjacent abscesses and the degree of active inflammation which can in 
turn guide management [58, 59].
7.2. Endocytoscopy and endomicroscopy
Endopathology, which includes both endocytoscopy (EC) and confocal laser endomicroscopy 
(CLE), allows for magnification of the mucosal surface and real-time histologic assessment 
at the time of endoscopy. EC and CLE can be performed with stand-alone probes that are 
advanced through an endoscope or via probes integrated into the distal end of an endoscope. 
Endocytoscopy typically requires N-acetylcysteine for mucolysis followed by topical appli-
cation of a staining agent. CLE allows for tissue magnification by illumination with a low 
power laser light that is reflected through a pinhole and requires either a topical agent or an 
intravenous fluorescence agent, usually fluorescein sodium, for adequate visualization [60, 61]. 
Magnification assessment by EC allows for the detection of mucosal inflammatory cells, crypt 
assessment, and nucleus-cytoplasm ratio, whereas CLE can assess crypt architecture, inflam-
matory cell infiltrate, and vessel architecture but fluorescein does not allow for nuclear visu-
alization and assessment. Both EC and CLE have excellent correlation with histology in IBD 
and can diagnose inflammatory and architectural changes even if the mucosa appears normal 
endoscopically [62, 63]. Both EC and CLE may allow for identification of microscopic changes 
that can predict relapse in established IBD patients in remission, but their role in diagnosis at 
this time is unclear. EC and CLE are areas undergoing active investigation and do not yet have 
widespread applicability.
7.3. Spectroscopy
Elastic scattering spectroscopy, reflectance spectroscopy, and fluorescence spectroscopy 
have shown promise for the diagnosis of IBD. In addition to aiding in the diagnosis of IBD, 
Raman spectroscopy has evidence that shows promise for the differentiation of CD and 
UC. Spectroscopy in general provides a unique tissue signature that is based on the makeup of 
the tissue and its interaction with light and is different in normal compared to inflamed tissue. 
Scattering spectroscopy provides information based on the microscopic structure, whereas 
Raman spectroscopy and fluorescence spectroscopy provide data based on the biochemical 
makeup of the tissue [64–66]. Spectroscopy in general shows promise for the diagnosis of IBD 
but needs further evaluation.
7.4. Optical coherence tomography
Optical coherence tomography (OCT) generates a cross-sectional image of the internal micro-
structure by measuring back-reflected light. OCT can evaluate tissue to a depth of at the least 
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the muscularis propria in most patients and provides information on transmural inflamma-
tion by identifying disruption of the layered stricture of the bowel wall. Such disruption on 
OCT can therefore help differentiate CD from UC [67, 68]. OCT also requires further study 
before clinical application.
8. Conclusion
The most important test for the diagnosis of IBD is colonoscopy with ileoscopy being a criti-
cal component in initial testing. Capsule endoscopy can be a useful tool when the diagnosis 
is uncertain and certainly in patients with disease on radiographic studies out of reach of 
standard ileo-colonoscopy. In addition CE has a similar or higher sensitivity compared to 
small bowel imaging modalities. In terms of mucosal appearance, continuous inflammation 
from the anal verge proximally is consistent with UC whereas discontinuous inflammation 
with ileitis, upper GI or other small inflammation and the presence of stricturing or fistulizing 
disease is diagnostic for CD over UC. However, the mucosal appearance of the inflammation 
is not 100% specific for either disease. Appropriate attention should be made to obtaining 
biopsies to increase the diagnostic yield of the procedure. At least two biopsies should be 
taken from five sites during ileocolonoscopy including the ileum and rectum and normal 
and abnormal appearing mucosa. The diagnosis of IBD relies upon a combination of history, 
radiography, laboratory, and endoscopic features, with ileocolonoscopy providing the most 
accurate and useful data.
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